Staphylococcus aureus DSM 11823 is a mesophilic human pathogen that was isolated from clinical material.
mesophilic human pathogen| @ref 20215 |
Last LPSN update
2025-12-16 09:50:21 |
| Domain Bacillati |
| Phylum Bacillota |
| Class Bacilli |
| Order Caryophanales |
| Family Staphylococcaceae |
| Genus Staphylococcus |
| Species Staphylococcus aureus |
| Full scientific name Staphylococcus aureus Rosenbach 1884 (Approved Lists 1980) |
| Synonyms (2) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 4504 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive  | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 4504 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | Medium recipe at MediaDive | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water |
| @ref | Growth | Type | Temperature (°C) | Range | |
|---|---|---|---|---|---|
| 4504 | positive | growth | 37 | mesophilic |
| Test 1 | |
|---|---|
| @ref | 4504 |
| Medium | Müller-Hinton Agar |
| Incubation temperature | 37 |
| Oxygen condition | aerob |
| Manual_annotation | 1 |
| Inhibition zone diameter in mm | |
| Ampicillin | 44 |
| Oxacillin | 36 |
| Penicillin G | 44-46 |
| Aztreonam | 0 |
| Ticarcillin | 50 |
| Cefotaxime | 32-34 |
| Ceftazidime | 20 |
| Ceftriaxone | 30 |
| Cefiderocol | 16 |
| Piperacillin/Tazobactam | 44 |
| Imipenem | 50 |
| Meropenem | 40 |
| Ciprofloxacin | 36 |
| Levofloxacin | 36 |
| Moxifloxacin | 40 |
| Ofloxacin | 32 |
| Amikacin | 28 |
| Gentamicin | 28 |
| Tetracycline | 36 |
| Tigecycline | 30-32 |
| Teicoplanin | 18 |
| Vancomycin | 20 |
| Polymyxin B | 12 |
| Colistin sulphate | 0 |
| Clindamycin | 36 |
| Erythromycin | 32 |
| Fosfomycin | 50 |
| Kanamycin | 28 |
| Chloramphenicol | 30 |
| Linezolid | 36-38 |
| Nitrofurantoin | 22 |
| Quinupristin/Dalfopristin | 28-30 |
| Rifampicin | 36 |
| Trimethoprim-sulfamethoxazole (1:19) | 34 |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68375 | 22599 ChEBI | arabinose | - | fermentation | from API ID32STA |
| 68375 | 29016 ChEBI | arginine | + | hydrolysis | from API ID32STA |
| 68375 | 17057 ChEBI | cellobiose | - | fermentation | from API ID32STA |
| 68375 | 15824 ChEBI | D-fructose | + | fermentation | from API ID32STA |
| 68375 | 17634 ChEBI | D-glucose | + | fermentation | from API ID32STA |
| 68375 | 16899 ChEBI | D-mannitol | + | fermentation | from API ID32STA |
| 68375 | 16024 ChEBI | D-mannose | + | fermentation | from API ID32STA |
| 68375 | 16988 ChEBI | D-ribose | - | fermentation | from API ID32STA |
| 68375 | 4853 ChEBI | esculin | - | hydrolysis | from API ID32STA |
| 68375 | 17716 ChEBI | lactose | + | fermentation | from API ID32STA |
| 68375 | 17306 ChEBI | maltose | + | fermentation | from API ID32STA |
| 68375 | 59640 ChEBI | N-acetylglucosamine | + | fermentation | from API ID32STA |
| 68375 | 17632 ChEBI | nitrate | + | reduction | from API ID32STA |
| 68375 | 18257 ChEBI | ornithine | - | degradation | from API ID32STA |
| 68375 | 17992 ChEBI | sucrose | + | fermentation | from API ID32STA |
| 68375 | 27082 ChEBI | trehalose | + | fermentation | from API ID32STA |
| 68375 | 32528 ChEBI | turanose | + | fermentation | from API ID32STA |
| 68375 | 16199 ChEBI | urea | + | hydrolysis | from API ID32STA |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68375 | alkaline phosphatase | + | 3.1.3.1 | from API ID32STA |
| 68375 | arginine dihydrolase | + | 3.5.3.6 | from API ID32STA |
| 68375 | beta-glucosidase | - | 3.2.1.21 | from API ID32STA |
| 68375 | beta-glucuronidase | - | 3.2.1.31 | from API ID32STA |
| 68375 | L-arginine arylamidase | - | from API ID32STA | |
| 68375 | ornithine decarboxylase | - | 4.1.1.17 | from API ID32STA |
| 68375 | pyrrolidonyl arylamidase | - | 3.4.19.3 | from API ID32STA |
| 68375 | urease | + | 3.5.1.5 | from API ID32STA |
| @ref | URE | ADH (Arg) | ODC | ESC | GLU | FRU | MNE | MAL | LAC | TRE | MAN | RAF | RIB | CEL | Reduction of nitrateNIT | Acetoin production (Voges Proskauer test)VP | beta GAL | L-arginine arylamidaseArgA | PAL | Pyrrolidonyl arylamidasePyrA | NOVO | SAC | NAG | TUR | ARA | beta GUR | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4504 | + | + | - | - | + | + | + | + | + | + | + | - | - | - | + | +/- | +/- | - | + | - | + | + | + | + | - | - | |
| 4504 | + | + | - | - | + | + | + | + | + | + | + | +/- | - | - | + | + | - | - | + | - | - | + | + | + | - | - |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Biotechnology | Validation of the Peel Plate Staphylococcus Aureus (SA) Test for Enumeration of S. aureus in Selected Foods and Non-Cultured Dairy Products: AOAC Performance Tested MethodSM 082401. | Salter RS, Durbin GW, Li S, Gilbert M, Crowley ES, Deterding A, Bastin B. | J AOAC Int | 10.1093/jaoacint/qsae083 | 2025 | |
| The skin microbiome stratifies patients with cutaneous T cell lymphoma and determines event-free survival. | Licht P, Dominelli N, Kleemann J, Pastore S, Muller ES, Haist M, Hartmann KS, Stege H, Bros M, Meissner M, Grabbe S, Heermann R, Mailander V. | NPJ Biofilms Microbiomes | 10.1038/s41522-024-00542-4 | 2024 | | |
| Molecular Profiling of Keratinocyte Skin Tumors Links Staphylococcus aureus Overabundance and Increased Human beta-Defensin-2 Expression to Growth Promotion of Squamous Cell Carcinoma. | Madhusudhan N, Pausan MR, Halwachs B, Durdevic M, Windisch M, Kehrmann J, Patra V, Wolf P, Boukamp P, Moissl-Eichinger C, Cerroni L, Becker JC, Gorkiewicz G. | Cancers (Basel) | 10.3390/cancers12030541 | 2020 | | |
| Pathogenicity | Comparative mutant prevention concentrations of pradofloxacin and other veterinary fluoroquinolones indicate differing potentials in preventing selection of resistance. | Wetzstein HG. | Antimicrob Agents Chemother | 10.1128/aac.49.10.4166-4173.2005 | 2005 | |
| Enzymology | Highly Effective Inhibition of Biofilm Formation by the First Metagenome-Derived AI-2 Quenching Enzyme. | Weiland-Brauer N, Kisch MJ, Pinnow N, Liese A, Schmitz RA. | Front Microbiol | 10.3389/fmicb.2016.01098 | 2016 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive14462.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License